Titan Pharmaceuticals Reports $763,000 Q3 Loss
Titan Pharmaceuticals faces a $763,000 loss in Q3, impacting its financial outlook. Explore the Q3 results and future prospects in this financial report.
![A sleek, modern design showcasing Titan Pharmaceuticals' logo, with a subtle graph overlay indicatin](https://assets.mulai.pw/finance-pulse/default_h.jpg)
Titan Pharmaceuticals reported a third-quarter loss of $763,000.